📰 Quest Diagnostics News
Page 71 - Quest Diagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Quest Diagnostics. Real-time updates on events, politics, business and more.
December 6, 2023
/PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the worlds leading provider of diagnostic information services, today announced that for the seventh straight...
December 6, 2023
Merck takes the top spot in Newsweeks fifth annual list of
December 5, 2023
/PRNewswire/ -- The "C Reactive Protein Testing Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to...
December 5, 2023
Reesha Ahmed was on cloud nine.
December 5, 2023
BioAffinity Technologies, Inc. , a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer and lung disease, today announced the appointment of Jamie...
November 30, 2023
MARLBOROUGH, MA - National multifamily real estate development leader Wood Partners has officially announced the start of construction on Alta French Hill, the companys latest upscale residential community, located in Marlborough, Massachusetts. Pre-leasing opportunities are set to commence in 2024, and the community is scheduled to welcome residents in February 2025. Situated at 303 Lincoln Street and neighboring the Assabet River Rail Trail, Alta French Hill will provide residents with...
November 30, 2023
Ontario Teachers Pension Plan Board lowered its stake in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 17.1% during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 22,745 shares of the medical research company’s stock after selling 4,703 shares during the quarter. Ontario Teachers […]
November 28, 2023
Quest Volunteers Bring Treats, No Tricks, to Ronald McDonald House ...
November 28, 2023
StockNews.com upgraded shares of Quest Diagnostics (NYSE:DGX – Free Report) from a hold rating to a buy rating in a research note issued to investors on Friday. Several other equities analysts have also issued reports on DGX. Evercore ISI reduced their target price on Quest Diagnostics from $136.00 to $130.00 in a report on Wednesday, […]
November 28, 2023
Relationship leverages Quests sequencing and specimen collection expertise with Sciphers precision medicine technology SECAUCUS, N.J. and WALTHAM, Mass., Nov. 28, 2023 /PRNewswire/ -- Quest...